Ctxr stock forecast 2025.

In a report released on May 4, Dawson James also maintained a Buy rating on the stock with a $8.00 price target. See Insiders’ Hot Stocks on TipRanks >> CTXR market cap is currently $187.5M and ...

Ctxr stock forecast 2025. Things To Know About Ctxr stock forecast 2025.

The average Viatris stock price prediction forecasts a potential upside of 9.45% from the current VTRS share price of $10.05. What is VTRS's forecast return on assets (ROA) for 2023-2026? (NASDAQ: VTRS) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%. ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Atara Biotherapeutics share forecasts, stock quote and buy / sell signals below. According to present data Atara Biotherapeutics's ATRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Price target. 15.15 0.00 0.00%. The 6 analysts offering 1 year price forecasts for GTE have a max estimate of — and a min estimate of —.The Snapchat stock price gained 3.29% on the last trading day (Wednesday, 11th Oct 2023), rising from $8.82 to $9.11. During the last trading day the stock fluctuated 3.51% from a day low at $8.82 to a day high of $9.13. The price has risen in 6 of the last 10 days and is up by 7.3% over the past 2 weeks.

About the Caesars Entertainment, Inc. stock forecast. As of 2023 October 10, Tuesday current price of CZR stock is 46.240$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. CITIC Resources Holdings stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame.The weighted average target price per The Charles Schwab share in Nov 2025 is: 60.24. In Nov, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 10.225% volatility is expected. Pessimistic target level: 55.27. Optimistic target level: 61.56.

CTXR US17322U2078 Biotechnology & Medical Research Delayed ... 2025 Capitalization 1: 27,7 21,8 57,7 296 ... Stock Citius Pharmaceuticals, Inc. - Nasdaq ...Entering text into the input field will update the search result below

Cisco Systems, Inc. () Stock Market info Recommendations: Buy or sell Cisco Systems stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cisco Systems share forecasts, stock quote and buy / sell signals below.According to present data Cisco Systems's CSCO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if ...The 12-month price forecast for Rivian stock as of August 2023 is $28.32. That figure represents the consensus of 19 Wall Street analysts. However, the highest analyst prediction estimates Rivian stock could be as high as $44 12 months from now. The most bearish analyst has a 12-month price target of just $12 per share.Navidea Biopharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Navidea Biopharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Navidea Biopharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Navidea Biopharmaceuticals's NAVB …The ESSA Pharma Inc. stock price gained 1.03% on the last trading day (Thursday, 5th Oct 2023), rising from $2.91 to $2.94. During the last trading day the stock fluctuated 5.00% from a day low at $2.80 to a day high of $2.94. The price has risen in 6 of the last 10 days and is up by 4.63% over the past 2 weeks.The Riot Blockchain stock price gained 10.10% on the last trading day (Friday, 6th Oct 2023), rising from $9.01 to $9.92. During the last trading day the stock fluctuated 13.65% from a day low at $8.78 to a day high of $9.98. The price has been going up and down for this period, and there has been a 7.36% gain for the last 2 weeks.

Citius Pharmaceuticals Stock Earnings. The value each CTXR share was expected to gain vs. the value that each CTXR share actually gained. Citius Pharmaceuticals ( CTXR) reported Q2 2023 earnings per share (EPS) of -$0.06, meeting estimates of -$0.06 by 8.17%. In the same quarter last year, Citius Pharmaceuticals 's earnings per share (EPS) was ...

The put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ...

Stock Price Forecast. The 14 analysts offering 12-month price forecasts for Curaleaf Holdings Inc have a median target of 5.38, with a high estimate of 13.00 and a low estimate of 2.75. The median ...The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 488.49% upside from the last price of $0.68. This chart shows the closing price for CTXR for the last year in relation to the current analyst high, average, and low pricetarget.Forty percent of the $1.5 billion market is $600 million. The average price-to-sales ratio (P/S) for a biotech stock is 8.09. That means when we multiply the yearly revenue of $600 million by the ...Analyst Predictions. 3. What is CTXR stock forecast (i.e., prediction)? Based on CTXR analyst price targets, CTXR stock forecast is $7.00 (for a year from now). That means the average analyst price target for CTXR stock is $7.00. The prediction is based on 2 analyst estimates. The low price target for CTXR is $4.00, while the high price target ...Citius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CTXR updated stock price target summary.Citius Pharmaceuticals (CTXR) will release its next earnings report on Dec 13, 2023. In the last quarter Citius Pharmaceuticals reported -$0.06 EPS in relation to -$0.06 expected by the market. ... Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Citius Pharmaceuticals Stock Forecast. Is Citius Pharmaceuticals Stock Undervalued? The current Citius Pharmaceuticals [ CTXR] share price is $0.67. The Score for CTXR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal. CTXR is currently trading in the 30-40% percentile range relative to its historical ...US17322U2078. Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.The average Viatris stock price prediction forecasts a potential upside of 9.45% from the current VTRS share price of $10.05. What is VTRS's forecast return on assets (ROA) for 2023-2026? (NASDAQ: VTRS) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%. According to our current ROKU stock forecast, the value of Roku shares will rise by 11.54% and reach $ 80.14 per share by October 13, 2023. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).ROKU stock recorded 14/30 (47%) green days with 8.01% price volatility over the last 30 days.View the basic CTXR option chain and compare options of Citius Pharmaceuticals, Inc. on Yahoo Finance.The Riot Blockchain stock price gained 10.10% on the last trading day (Friday, 6th Oct 2023), rising from $9.01 to $9.92. During the last trading day the stock fluctuated 13.65% from a day low at $8.78 to a day high of $9.98. The price has been going up and down for this period, and there has been a 7.36% gain for the last 2 weeks.Based on 19 Wall Street analysts offering 12 month price targets for Sunrun in the last 3 months. The average price target is $32.00 with a high forecast of $60.00 and a low forecast of $12.00. The average price target represents a 168.23% change from the last price of $11.93. Highest Price Target $60.00. Average Price Target $32.00.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...

View real-time stock prices and stock quotes for a full financial overview. Citius Pharmaceuticals Inc Stock - CTXR Share Price Today, News ... Current Price, $1.07 ; Prev Close, $1.14 ; Open, $1.13 ; Dividend Yield, 0.00% ; 50-Day Moving Average, $1.15.3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. Track Catamaran Corp. (CTRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.According to our Citius Pharmaceuticals stock prediction for 2025, CTXR stock will be priced at $ 0.617066 in 2025. This forecast is based on the stock’s average growth over the past 10 years. What is the Citius Pharmaceuticals stock prediction for 2030?Corus Entertainment Stock Predictions 2025 Stock Forecast for the Price of an Corus Entertainment Share in Jan 2025. In January 2025, analysts believe the stock price will be C$4.94. An increase of 425.08% compared to the previous month's estimate.Oct 15, 2020 · The Citius Pharmaceuticals stock forecast is 1.4385934555248 USD for 2024 September 28, Saturday; and 4.929 USD for 2028 September 28, Thursday with technical analysis. Citius Pharmaceuticals (CTXR) stock price prediction is 1.4385934555248 USD. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingMar 2023 , the consensus EPS* forecast has ...View the basic CTXR option chain and compare options of Citius Pharmaceuticals, Inc. on Yahoo Finance.CTXR - Citius Pharmaceuticals Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Citius Pharmaceuticals Inc (NASDAQ:CTXR) 0.694 Delayed Data As of 3:59pm ET -0.006 / -0.86%...

Their PRAX share price forecasts range from $2.00 to $10.00. On average, they expect the company's share price to reach $6.33 in the next twelve months. This suggests a possible upside of 313.9% from the stock's current price. View analysts price targets for PRAX or view top-rated stocks among Wall Street analysts.

The Trend in the Analyst Price Target. CTXR's average price target has moved down $0.67 over the prior 26 months. CTXR reports an average of 503.1% for its upside potential over the past 46 weeks. Date. Number of Analysts.

CTXR - Citius Pharmaceuticals Inc Stock Price Quote - NASDAQ | Morningstar Citius Pharmaceuticals Inc CTXR Morningstar Rating | Rating as of Oct 4, …Bit Digital Inc () Stock Market info Recommendations: Buy or sell Bit Digital stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bit Digital share forecasts, stock quote and buy / sell signals below.According to present data Bit Digital's BTBT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).CTXR : Citius Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisCitius Pharmaceuticals, Inc. [CTXR] Stock Forecast. Candles Line. Buy or Sell ? Support and Resistance ... How RSI can help? RSI : 000. CTXR Stock Summary. CTXR has more than 2 years of cash runway (27 months) An RSI reading of 30 or below indicates an oversold or undervalued condition. Top 10 Correlated ETFs CTXR. Top 10 Correlated Stocks ...Target values for the price of one CrowdStrike Holdings share for Nov 2025. The weighted average target price per CrowdStrike Holdings share in Nov 2025 is: 125.06. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 12.881% volatility is expected. Pessimistic target level: 119.86.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 8.00 and a low estimate of 4.00. The ... Their OCGN share price forecasts range from $2.00 to $5.00. On average, they anticipate the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 725.3% from the stock's current price. View analysts price targets for OCGN or view top-rated stocks among Wall Street analysts.View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

CTXR - Citius Pharmaceuticals Inc Stock Price Quote - NASDAQ | Morningstar Citius Pharmaceuticals Inc CTXR Morningstar Rating | Rating as of Oct 4, …Citius Pharmaceuticals Inc (CTXR) stock is trading at $1.13 as of 12:52 PM on Friday, Feb 24, a drop of -$0.05, or -4.24% from the previous closing price of $1.18. The stock has traded between $1.13 and $1.19 so far today. Volume today is low.Exxon Mobil Corp Stock Forecast 2023. In the last five quarters, Exxon Mobil Corp's Price Target has risen from $66.23 to $119.84 - a 80.95% increase. Fourteen analysts predict that Exxon Mobil Corp's share price will increase in the coming year, reaching $122.00. This would represent an increase of 1.8%.CTXR Technical Analysis. The following CTXR technical analysis is based on short term price movement and trend analysis. The analysis is useful for short term traders who trade stocks with technical anlaysis. CTXR is up 1.45% on 09/22/23. CTXR is trading in the range of $0.69 - $0.99 in the past 30 days. Bullish Indicators Bearish IndicatorsInstagram:https://instagram. water temp at ky lakekbi offender searchpontiac il obitsallergy partners waynesboro CTXR Stock Forecast, Price Targets and Analysts Predictions Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $7.00 with a high ... when is big meech being released from prisonindianapolis hourly forecast Citrix Systems, Inc. () Stock Market info Recommendations: Buy or sell Citrix Systems stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Citrix Systems share forecasts, stock quote and buy / sell signals below.According to present data Citrix Systems's CTXS shares and potentially its market environment have been in a bullish cycle in the last 12 months ...Oct 9, 2023 · Corporate Overview. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. honda dealership lake worth Based on 19 Wall Street analysts offering 12 month price targets for Sunrun in the last 3 months. The average price target is $32.00 with a high forecast of $60.00 and a low forecast of $12.00. The average price target represents a 168.23% change from the last price of $11.93. Highest Price Target $60.00. Average Price Target $32.00. Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Citius Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.